Physician profile
Amresh Kumar
NPI 1154811230
$5,996.01
in general payments reported to CMS, 2019-2025
7 companies · $5,717 in 2025
The $5,717 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $265 · 2023: $13.71 · 2025: $5,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,838 · Travel and Lodging: $1,420 · Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,837.50 |
| Travel and Lodging | $1,420.18 |
| Food and Beverage | $472.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $5,409.51 | 2025 | |
| Horizon Therapeutics Plc | $248.31 | 2022 | |
| Mallinckrodt Hospital Products INC. | $142.44 | 2025 | Terlivaz |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $116.33 | 2025 | |
| Apellis Pharmaceuticals, INC. | $48.59 | 2025 | Empaveli |
| Nxstage Medical, INC. | $17.12 | 2022 | |
| Vifor Pharma, INC. | $13.71 | 2023 | Veltassa, Korsuva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amresh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.